For the Inventor, By the Inventor

Enter assignee name

Gaithersburg, MD, United States of America

Antex Biologics, Inc.

USPTO Granted Patents = 18

CIPO Patents = 5

Forward Citations = 116

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

John L Pace (11 out of 22 patents)

Steven Michael Frey (9 out of 9 patents)

Richard Ives Walker (9 out of 9 patents)

4. W James Jackson (4 out of 12 patents)

5. James E Samuel (3 out of 9 patents)

6. Howard C Krivan (3 out of 7 patents)

7. Andrea M Harris (2 out of 2 patents)

8. Kenneth D Tucker (2 out of 11 patents)

9. Laura Plosila (1 out of 5 patents)

10. Ulrich F Tillman (1 out of 4 patents)

11. Ulrich F Tillmann (1 out of 2 patents)

12. Clifford A Lingwood (18 patents)

13. Bo Nilsson (0 patent)

14. Arne L Blomberg (0 patent)

15. Kenneth Tucker (0 patent)

18 patents: Sort by Forward Citations

1. 6887843 - Chlamydia protein, gene sequence and uses thereof (2005-05-03),

2. 6756493 - Nucleic acid sequence and uses thereof (2004-06-29),

3. 6693186 - Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof (2004-02-17),

4. 6642023 - Chlamydia protein, gene sequence and uses thereof (2003-11-04),

5. 6541616 - Moraxella catarrhalis protein, gene sequence and uses thereof (2003-04-01),

6. 6214981 - Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof (2001-04-10),

7. 6083683 - Methods for detecting shigella bacteria or antibodies to shigella (2000-07-04),

8. 6077678 - Methods for detecting Campylobacter bacteria or antibodies to (2000-06-20),

9. 6051416 - Methods for producing enhanced antigenic Helicobacter sp. (2000-04-18),

10. 5976525 - Method for producing enhanced antigenic enteric bacteria (1999-11-02),

11. 5897475 - Vaccines comprising enhanced antigenic helicobacter spp. (1999-04-27),

12. 5869066 - Vaccine containing a campylobacter bacterium having an enhanced (1999-02-09),

13. 5858352 - Vaccine containing a Shigella bacterium having an enhanced antigenic (1999-01-12),

14. 5843463 - Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae (1998-12-01),

15. 5721115 - DNA encoding a novel Haemophilus influenzae protein (1998-02-24),

Antex Biologics, Inc. is a leading biotechnology company dedicated to developing innovative solutions in the field of immunotherapy. With a focus on cutting-edge research and development, Antex Biologics aims to revolutionize the way we approach infectious diseases and health challenges. Through a commitment to excellence and a passion for improving patient outcomes, Antex Biologics is at the forefront of advancing medical science.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

18 Patents

#21 in Gaithersburg, MD

#234 in Maryland

#17,382 in US

#33,147 in the World

Gaithersburg, MD, United States of America

Antex Biologics, Inc.

Forward Citations = 116

15 inventors:

John L Pace (11 out of 22 patents)

Steven Michael Frey (9 out of 9 patents)

Richard Ives Walker (9 out of 9 patents)

4. W James Jackson (4 out of 12 patents)

5. James E Samuel (3 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…